202. Good News for Triple Negative Breast Cancer: A Vaccine and Hope for the Future episode artwork

EPISODE · Jul 23, 2023 · 51 MIN

202. Good News for Triple Negative Breast Cancer: A Vaccine and Hope for the Future

from Breast Cancer Conversations · host SurvivingBreastCancer.org

Love the podcast? Send us a text!In this episode, Laura Carfang interviews  Dr. Kumar, the chairman and CEO of Anixa Biosciences , and Jenni Davis, the first recipient of the triple-negative breast cancer (TNBC) vaccine, which is currently in preliminary clinical trial phases.  The vaccine is designed to prevent recurrence of breast cancer in survivors and eventually prevent cancer onset in women and men who have never had breast cancer before. It specifically focuses on triple-negative breast cancer but may have the potential to prevent other types of breast cancer as well.  Both Dr. Kumar and Jenni express excitement and hope for the future of the vaccine and its potential to improve breast cancer prevention and treatment.Topics in this Episode:[00:01:48] The triple negative breast cancer vaccine.[00:04:30] Breast cancer diagnosis and treatment.[00:09:28] Reconstruction complications and alternatives.[00:13:45] The brutal process of cancer.[00:18:07] Eligibility for vaccine trial.[00:19:41] The first human vaccine recipient.[00:24:50] Clinical trials and their importance.[00:27:59] Vaccine effectiveness in preventing breast cancer.[00:31:01] Vaccinating against breast cancer.[00:35:43] Vaccine side effects.[00:39:45] Unique breast cancer trial.[00:43:41] How the vaccine works.[00:46:39] Eliminating breast cancer as a disease.As always, our podcasts are made possible thanks to donations from listeners like you. If you would like to support our nonprofit organization, please consider making a contribution through survivingbreastcancer.org/donate.Don't forget to also check out all of our free programming and services available to anyone who has been diagnosed with breast cancer. Visit survivingbreastcancer.org/events for more information.Thank you for being a part of our community and for supporting our mission to empower those diagnosed with breast cancer and their caregivers.About SurvivingBreastCancer.org. Survivingbreastcancer.org (SBC) was created in 2017 to help fill the gaps in breast cancer support, education, and resources. It was founded by Laura Carfang,  who was recently diagnosed at that time in her early 30’s.  Since 2017, SBC has grown exponentially, serving members in the global breast cancer community.  Over these past few years, the SBC website has been visited by community members (over 1,000,000 page views) across 120+ plus countries, and Laura’s podcast, Breast Cancer Conversations has been listened to in over 80 countries. Leveraging technology and breaking down barriers to access and information, SBC puts the patient first, educating, encouraging and inspiring advocacy.  Community members are encouraged to participate in the various free programming, events and services and are all invited to contribute to resolving the growing needs of this population. Website:https://www.survivingbreastcancer.org/Donate NowPlease consider making a donation.https://www.survivingbreastcancer.org/donate-nowSupport the showSupport the showListener FeedbackIf this episode resonated with you, we invite you to leave a review on Apple Podcasts or Spotify.You can also click the link in the show notes that says "Love this episode? Send us a text" to share feedback.Messages are completely anonymous.If you would like us to follow up directly, please include your email address in your message so we can respond.Latest News: Join our Mailing List - New content drops every Monday! Discover FREE programs, support groups, and resources from SurvivingBReastCancer.org! Become a Breast Cancer Conversations+ Member! Sign Up Now. Enjoying our content? Please consider supporting our work. 

Love the podcast? Send us a text! In this episode, Laura Carfang interviews Dr. Kumar, the chairman and CEO of Anixa Biosciences , and Jenni Davis, the first recipient of the triple-negative breast cancer (TNBC) vaccine, which is currently in preliminary clinical trial phases. The vaccine is designed to prevent recurrence of breast cancer in survivors and eventually prevent cancer onset in women and men who have never had breast cancer before. It specifically focuses on triple-neg...

NOW PLAYING

202. Good News for Triple Negative Breast Cancer: A Vaccine and Hope for the Future

0:00 51:31

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Breast Cancer Conversations?

This episode is 51 minutes long.

When was this Breast Cancer Conversations episode published?

This episode was published on July 23, 2023.

What is this episode about?

Love the podcast? Send us a text!In this episode, Laura Carfang interviews  Dr. Kumar, the chairman and CEO of Anixa Biosciences , and Jenni Davis, the first recipient of the triple-negative breast cancer (TNBC) vaccine, which is currently in...

Can I download this Breast Cancer Conversations episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!